WO2005046727A3 - Ibuprofen-containing soft gelatin capsules - Google Patents

Ibuprofen-containing soft gelatin capsules Download PDF

Info

Publication number
WO2005046727A3
WO2005046727A3 PCT/IB2004/003717 IB2004003717W WO2005046727A3 WO 2005046727 A3 WO2005046727 A3 WO 2005046727A3 IB 2004003717 W IB2004003717 W IB 2004003717W WO 2005046727 A3 WO2005046727 A3 WO 2005046727A3
Authority
WO
WIPO (PCT)
Prior art keywords
ibuprofen
gelatin capsules
soft gelatin
containing soft
manufacture
Prior art date
Application number
PCT/IB2004/003717
Other languages
French (fr)
Other versions
WO2005046727A2 (en
Inventor
Inderdeep Singh Bhatia
Ajay Kumar Singla
Sanjeev Sethi
Original Assignee
Ranbaxy Lab Ltd
Inderdeep Singh Bhatia
Ajay Kumar Singla
Sanjeev Sethi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd, Inderdeep Singh Bhatia, Ajay Kumar Singla, Sanjeev Sethi filed Critical Ranbaxy Lab Ltd
Priority to EP04798849A priority Critical patent/EP1684732A2/en
Publication of WO2005046727A2 publication Critical patent/WO2005046727A2/en
Publication of WO2005046727A3 publication Critical patent/WO2005046727A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The technical field of the invention relates to ibuprofen-containing soft gelatin capsules, pharmaceutical compositions of a substantially clear ibuprofen solution, and process for their manufacture.
PCT/IB2004/003717 2003-11-12 2004-11-12 Ibuprofen-containing soft gelatin capsules WO2005046727A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP04798849A EP1684732A2 (en) 2003-11-12 2004-11-12 Ibuprofen-containing soft gelatin capsules

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1394/DEL/2003 2003-11-12
IN1394DE2003 2003-11-12

Publications (2)

Publication Number Publication Date
WO2005046727A2 WO2005046727A2 (en) 2005-05-26
WO2005046727A3 true WO2005046727A3 (en) 2005-08-25

Family

ID=34586955

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2004/003717 WO2005046727A2 (en) 2003-11-12 2004-11-12 Ibuprofen-containing soft gelatin capsules

Country Status (2)

Country Link
EP (1) EP1684732A2 (en)
WO (1) WO2005046727A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8808740B2 (en) 2010-12-22 2014-08-19 Purdue Pharma L.P. Encased tamper resistant controlled release dosage forms
US9149533B2 (en) 2013-02-05 2015-10-06 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005123133A1 (en) * 2004-06-18 2005-12-29 Ranbaxy Laboratories Limited A process for preparing ibuprofen soft gelatin capsules
US9238073B2 (en) * 2006-04-12 2016-01-19 Wyeth Llc Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive
PT2853262T (en) 2009-10-26 2017-01-31 Sephoris Pharmaceuticals Llc Treatment of sunburn using analgesics and antihistamines
KR20140075807A (en) 2010-12-23 2014-06-19 퍼듀 퍼머 엘피 Tamper resistant solid oral dosage forms
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9707184B2 (en) 2014-07-17 2017-07-18 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
WO2016140933A2 (en) * 2015-03-02 2016-09-09 Bionpharma Healthcare Llc Immediate release soluble ibuprofen compositions
WO2021011177A1 (en) * 2019-07-15 2021-01-21 R.P. Scherer Technologies, Llc Enteric proton pump inhibitor softgel capsule
GB2595300B (en) * 2020-05-21 2024-03-27 Reckitt Benckiser Health Ltd Novel Formulation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
GB2331458A (en) * 1997-11-21 1999-05-26 Gursharan Singh Moonga Solvent compositions for gelatin capsules
US6387400B1 (en) * 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
GB2331458A (en) * 1997-11-21 1999-05-26 Gursharan Singh Moonga Solvent compositions for gelatin capsules
US6387400B1 (en) * 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8808740B2 (en) 2010-12-22 2014-08-19 Purdue Pharma L.P. Encased tamper resistant controlled release dosage forms
US9393206B2 (en) 2010-12-22 2016-07-19 Purdue Pharma L.P. Encased tamper resistant controlled release dosage forms
US9572779B2 (en) 2010-12-22 2017-02-21 Purdue Pharma L.P. Encased tamper resistant controlled release dosage forms
US9149533B2 (en) 2013-02-05 2015-10-06 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
US9545448B2 (en) 2013-02-05 2017-01-17 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
US9579389B2 (en) 2013-02-05 2017-02-28 Purdue Pharma L.P. Methods of preparing tamper resistant pharmaceutical formulations

Also Published As

Publication number Publication date
WO2005046727A2 (en) 2005-05-26
EP1684732A2 (en) 2006-08-02

Similar Documents

Publication Publication Date Title
WO2005046727A3 (en) Ibuprofen-containing soft gelatin capsules
WO2004062577A3 (en) Two or more enteric materials to regulate drug release
ZA200203867B (en) alpha-Amino acids compounds, a process for their preparation and pharmaceutical compositions containing them.
WO2007146248A3 (en) Stable laquinimod preparations
WO2004072085A3 (en) Salt of a sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
WO2006125620A3 (en) Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
EP2133140A3 (en) Fast-release microcapsule products
ZA200202525B (en) α-amino acid sulphonyl compounds, a process for their preparation and pharmaceutical compositions containing them.
WO2004064806A3 (en) Process for modifying drug crystal formation
AR033711A1 (en) PHARMACEUTICAL COMPOSITIONS
WO2003087050A3 (en) Novel perindopril salt and pharmaceutical compositions containing same
WO2007144169A3 (en) Entacapone-derivatives
WO2003026610A3 (en) Process for the preparation of fast dissolving dosage form
BRPI0509524A (en) crystalline forms of n-desmethylclozapine
RS98704A (en) New pharmaceutical compositions containing flibanserin polymorpha
AU2003202719A1 (en) Novel antibacterial compounds:process for their preparation and pharmaceutical compositions containing them.
WO2005063219A3 (en) Ibuprofen-containing soft gelatin capsules
AU2003232941A1 (en) N-mercaptoacyl phenyalanine derivatives, process for their preparation, and pharmaceutical compositions containing them
WO2007007182A3 (en) Solid and liquid dosage forms of an antiepileptic agent
BRPI0408848B8 (en) pharmaceutical compositions of complex cyclodextrin-cladribine complex, uses of said complex, as well as processes for its preparation
AU2003231920A1 (en) Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
AU2003297927A1 (en) Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof
WO2004010972A3 (en) Pellicle-resistant gelatin capsule
WO2004075828A3 (en) Pharmaceutical composition of alendronic acid, salts or esters thereof, and a process for its preparation
EP2101742B8 (en) Pharmaceutical composition containing clopidogrel hydrogenesulphate of polymorph 1 form

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2449/DELNP/2006

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2004798849

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004798849

Country of ref document: EP